2026 Q3 Portfolio Activity
In 2026 Q3, STEMPOINT CAPITAL LP maintained a portfolio of 130 distinct positions. The most significant new addition was ADAPTIVE BIOTECHNOLOGIES COR, now representing 2.39% of the total fund value. They heavily accumulated shares in ERASCA INC, increasing the position by 1030.3%. The fund also reduced its exposure to REVOLUTION MEDICINES INC by 93.7%.
Position History
hover any row below to update
Loading…
Total Positions
130
Quarter
2026 Q3
Top Holding
SRRK (5.9%)
Top 10 Concentration
39.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 130
STEMPOINT CAPITAL LP Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 5.95% | 2.27% |
#1
11
Prev: #12
|
7.4 |
—
|
449,808 | 188.1% |
P
S
|
688,954 | $33,290,257 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ERAS
ERASCA INC
|
Healthcare | 5.92% | 4.94% |
#2
2
Prev: #4
|
6.4 |
—
|
694,681 | 44.4% |
P
S
|
2,260,594 | $33,140,308 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 4.94% | 6.51% |
#3
1
Prev: #2
|
3.5 |
—
|
-4,259 | -1.5% |
P
S
|
279,398 | $27,665,990 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 4.41% | 6.59% |
#4
3
Prev: #1
|
2.8 |
—
|
-233,674 | -19.1% |
P
S
|
989,345 | $24,684,158 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 4.19% | 2.12% |
#5
11
Prev: #16
|
5.2 |
—
|
293,065 | 84.1% |
P
S
|
641,473 | $23,458,668 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TRAX
FIRST TRACKS BI...
|
Healthcare | 4.12% | 2.16% |
#6
8
Prev: #14
|
2.1 |
—
|
27,201 | 4.4% |
P
S
|
649,924 | $23,033,307 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 2.71% | 3.03% |
#7
Prev: #7
|
1.6 |
—
|
-16,438 | -4.7% |
P
S
|
330,476 | $15,149,020 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 2.41% | 2.24% |
#8
5
Prev: #13
|
3.5 |
—
|
85,317 | 34.4% |
P
S
|
333,332 | $13,506,613 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ADPT
ADAPTIVE BIOTEC...
|
Healthcare | 2.39% | — |
#9
Prev: #—
|
4.5 |
—
|
463,551 | — |
NEW
|
463,551 | $13,396,624 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 2.37% | 3.37% |
#10
4
Prev: #6
|
0.9 |
—
|
-50,075 | -24.9% |
P
S
|
150,776 | $13,275,827 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SNSE
FAETH THERAPEUT...
|
Healthcare | 2.15% | — |
#11
Prev: #—
|
4.4 |
—
|
404,921 | — |
NEW
|
404,921 | $12,042,351 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 2.10% | 1.64% |
#12
12
Prev: #24
|
3.3 |
—
|
25,312 | 23.7% |
P
S
|
132,238 | $11,773,149 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMTX
IMMATICS N.V
|
Healthcare | 2.05% | — |
#13
Prev: #—
|
4.3 |
—
|
1,308,193 | — |
NEW
|
1,308,193 | $11,485,935 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GRAL
GRAIL INC
|
Healthcare | 2.05% | — |
#14
Prev: #—
|
4.3 |
—
|
81,924 | — |
NEW
|
81,924 | $11,479,191 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 2.02% | 2.15% |
#15
Prev: #15
|
1.3 |
—
|
1,477 | 4.0% |
P
S
|
38,720 | $11,276,426 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SRZN
SURROZEN INC
|
Healthcare | 1.99% | 2.37% |
#16
6
Prev: #10
|
0.8 |
—
|
-184,271 | -30.6% |
P
S
|
418,527 | $11,117,745 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CCCC
C4 THERAPEUTICS...
|
Healthcare | 1.96% | 0.42% |
#17
43
Prev: #60
|
3.8 |
—
|
2,769,728 | 528.9% |
P
S
|
3,293,376 | $10,966,942 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ACRS
ACLARIS THERAPE...
|
Healthcare | 1.93% | — |
#18
Prev: #—
|
4.3 |
—
|
2,050,698 | — |
NEW
|
2,050,698 | $10,786,671 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
N/A
DAMORA THERAPEU...
|
|
Unknown | 1.92% | — |
#19
Prev: #—
|
4.3 |
—
|
506,067 | — |
NEW
|
506,067 | $10,769,106 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 1.83% | 5.16% |
#20
17
Prev: #3
|
0.7 |
—
|
-109,943 | -68.7% |
P
S
|
50,000 | $10,263,000 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 1.72% | 1.11% |
#21
11
Prev: #32
|
3.7 |
—
|
70,157 | 92.8% |
P
S
|
145,760 | $9,607,042 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ONC
BEONE MEDICINES...
|
Healthcare | 1.64% | — |
#22
Prev: #—
|
4.2 |
—
|
25,051 | — |
NEW
|
25,051 | $9,167,163 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 1.48% | 0.79% |
#23
17
Prev: #40
|
3.6 |
—
|
146,212 | 192.2% |
P
S
|
222,287 | $8,266,854 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
JNJ
JOHNSON & JOHNS...
|
Healthcare | 1.42% | — |
#24
Prev: #—
|
4.1 |
—
|
30,000 | — |
NEW
|
30,000 | $7,942,200 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 1.41% | — |
#25
Prev: #—
|
4.1 |
—
|
552,245 | — |
NEW
|
552,245 | $7,908,148 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 1.36% | — |
#26
Prev: #—
|
4.0 |
—
|
6,599 | — |
NEW
|
6,599 | $7,635,571 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 1.29% | 0.55% |
#27
25
Prev: #52
|
3.5 |
—
|
70,728 | 180.4% |
P
S
|
109,926 | $7,194,657 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CERS
CERUS CORP
|
Healthcare | 1.26% | — |
#28
Prev: #—
|
4.0 |
—
|
2,967,942 | — |
NEW
|
2,967,942 | $7,063,702 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 1.22% | 1.84% |
#29
9
Prev: #20
|
0.5 |
—
|
-75,193 | -27.2% |
P
S
|
201,334 | $6,801,063 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
JBIO
JADE BIOSCIENCE...
|
Healthcare | 1.18% | — |
#30
Prev: #—
|
4.0 |
—
|
471,718 | — |
NEW
|
471,718 | $6,627,638 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GH
GUARDANT HEALTH...
|
Healthcare | 1.07% | — |
#31
Prev: #—
|
3.9 |
—
|
33,527 | — |
NEW
|
33,527 | $5,979,876 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
OABI
OMNIAB INC
|
Healthcare | 1.07% | — |
#32
Prev: #—
|
3.9 |
—
|
1,204,038 | — |
NEW
|
1,204,038 | $5,972,028 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 1.05% | — |
#33
Prev: #—
|
3.9 |
—
|
184,173 | — |
NEW
|
184,173 | $5,897,219 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 0.95% | 2.73% |
#34
25
Prev: #9
|
0.4 |
—
|
-667,335 | -62.7% |
P
S
|
396,865 | $5,298,148 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 0.90% | 2.80% |
#35
27
Prev: #8
|
0.4 |
—
|
-402,686 | -66.8% |
P
S
|
200,000 | $5,026,000 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 0.85% | — |
#36
Prev: #—
|
3.8 |
—
|
123,760 | — |
NEW
|
123,760 | $4,754,859 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CELC
CELCUITY INC
|
Healthcare | 0.82% | 1.77% |
#37
16
Prev: #21
|
0.3 |
—
|
-40,323 | -41.1% |
P
S
|
57,880 | $4,602,618 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GHRS
GH RESEARCH PLC
|
Healthcare | 0.82% | — |
#38
Prev: #—
|
3.8 |
—
|
195,143 | — |
NEW
|
195,143 | $4,581,958 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 0.81% | — |
#39
Prev: #—
|
3.8 |
—
|
111,577 | — |
NEW
|
111,577 | $4,530,026 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IFRX
INFLARX NV
|
Healthcare | 0.80% | 1.25% |
#40
14
Prev: #26
|
0.3 |
—
|
-743,022 | -23.0% |
P
S
|
2,485,233 | $4,473,419 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IPSC
CENTURY THERAPE...
|
Healthcare | 0.78% | 0.91% |
#41
6
Prev: #35
|
2.3 |
—
|
417,680 | 19.5% |
P
S
|
2,563,862 | $4,384,204 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BDSX
BIODESIX INC
|
Healthcare | 0.75% | 0.27% |
#42
24
Prev: #66
|
3.3 |
—
|
71,548 | 102.2% |
P
S
|
141,548 | $4,222,377 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BNTX
BIONTECH SE
|
Healthcare | 0.74% | — |
#43
Prev: #—
|
3.8 |
—
|
42,200 | — |
NEW
|
42,200 | $4,148,260 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SNY
SANOFI SA
|
Healthcare | 0.74% | — |
#44
Prev: #—
|
3.8 |
—
|
99,880 | — |
NEW
|
99,880 | $4,118,052 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AURA
AURA BIOSCIENCE...
|
Healthcare | 0.73% | 0.87% |
#45
9
Prev: #36
|
0.8 |
—
|
-66,874 | -9.4% |
P
S
|
647,406 | $4,065,710 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 0.69% | 1.95% |
#46
28
Prev: #18
|
0.3 |
—
|
-104,558 | -65.6% |
P
S
|
54,791 | $3,884,134 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 0.69% | 0.45% |
#47
10
Prev: #57
|
3.3 |
—
|
81,455 | 105.0% |
P
S
|
159,044 | $3,867,950 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KNSA
KINIKSA PHARMAC...
|
Healthcare | 0.69% | 2.30% |
#48
37
Prev: #11
|
0.3 |
—
|
-157,430 | -75.2% |
P
S
|
51,804 | $3,865,096 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.69% | — |
#49
Prev: #—
|
3.8 |
—
|
187,320 | — |
NEW
|
187,320 | $3,856,919 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 0.68% | — |
#50
Prev: #—
|
3.8 |
—
|
200,836 | — |
NEW
|
200,836 | $3,831,951 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-50 of 130 holdings